Submitting Debarment Certification Statements
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 2, 1998
May 5, 2020
02f51441-128a-4fc9-a874-1feac482d4d7
Related Documents
Ulcerative Colitis: Developing Drugs for Treatment
Guidance DocumentApril 28, 2022Center for Drug Evaluation and Research
Certification Process of Designated Medical Gases
Guidance DocumentNovember 25, 2015Center for Drug Evaluation and Research
How to Comply with the Pediatric Research Equity Act
Guidance DocumentSeptember 7, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.